MMedication Read More Doctors are using a regulatory gap to prescribe an unauthorized peptideJuly 24, 2026 Despite Health Canada’s warnings against the use of unauthorized peptides as a health and fitness shortcut, a CBC…
MMedication Read More Lilly to file for next-gen obesity drug approval in early 2027July 24, 2026 Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
MMedication Read More The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patientsJuly 24, 2026 GLP-1 medications have been shown to improve health and offer strong value for their price, yet many insurance…
MMedication Read More Trio to hold grand opening for functional medicine practice in Noblesville July 24, 2026 At the Root, a functional medicine practice at 210 N. 10th St. Suite 30, will celebrate its grand…
MMedication Read More U.S. health panel narrowly backs unapproved peptide drugs favoured by RFK Jr. and wellness influencers – CTV NewsJuly 24, 2026 U.S. health panel narrowly backs unapproved peptide drugs favoured by RFK Jr. and wellness influencers CTV NewsUS health panel…
MMedication Read More Novo’s Ozempic copy 15% cheaper, but Discovery still won’t change its positionJuly 24, 2026 Story audio is generated using AI Danish pharmaceutical manufacturer Novo Nordisk will launch its copy of its diabetes…
MMedication Read More Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic | HealthJuly 24, 2026 Australia’s medicines regulator has issued warnings for several type 2 diabetes and obesity-related treatments – including Ozempic and…
MMedication Read More Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic CancerJuly 24, 2026 Revolution Medicines, Inc. REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
MMedication Read More TGA issues new warning after finding link between GLP-1 medicines Ozempic, Wegovy, Mounjaro to eye disorderJuly 24, 2026 Australia’s medicine regulator has issued a safety warning over popular weight-loss drugs like Ozempic, saying they could cause…
MMedication Read More Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pillsJuly 24, 2026 (Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
MMedication Read More An FDA Panel Just Endorsed These Unproven PeptidesJuly 24, 2026 Peptides are inching closer to the mainstream. A panel of experts on Thursday narrowly recommended that the Food…
MMedication Read More TGA issues GLP-1 RA class-wide safety updateJuly 24, 2026 News Product warnings have been updated due to the high-profile treatment’s potential to cause a rare,…